GGrantIndex
Sort

27,075 grants matching cholesterol

Endothelial Rap1 restricts inflammation in the retina

$570,083
Magdalena Chrzanowska · Versiti Blood Health, Inc. · R01 · FY2025 · EY

Child maltreatment and cardiovascular disease risk: examining psychosocial and immunological pathways in a prospective, longitudinal cohort

$570,060
Hannah Milena Caroline Schreier · Pennsylvania State University, The · R01 · FY2024 · HL

Role of liver fat and fibrosis in human CVD risk phenotypes.

$570,016
Rohit Loomba · University Of California, San Diego · P01 · FY2020 · HL

Bisphenol A and Phthalate Exposure in Relation to Fetal Growth and Preterm Birth

$569,995
John D. Meeker · University Of Michigan At Ann Arbor · R01 · FY2010 · ES

Medical College of Georgia FitKid Project

$569,887
Paule Barbeau · Augusta University · R01 · FY2006 · DK

Natural Experiment of Neighborhood Revitalization and Cardiometabolic Health

$569,757
Wendy M Troxel · Rand Corporation · R01 · FY2017 · HL

Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM)

$569,717
Jeanie Beatrice Tryggestad · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2025 · DK

Proteomics of Cardiometabolic and Renal Traits in African Americans

$569,531
Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL

Fetal Lead Exposure, Genes, and Neurodevelopment

$569,522
Howard Hu · University Of Michigan At Ann Arbor · R01 · FY2007 · ES

Chicago Healthy Aging Low Risk MRI Angiography (CHARISMA) Study

$569,501
Donald M Lloyd-Jones · Northwestern University At Chicago · R01 · FY2009 · HL

Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c

$569,461
Michael S Brown · Ut Southwestern Medical Center · P01 · FY2015 · HL

Modeling DNA Diversity in Reverse Cholesterol Transport

$569,403
Charles F Sing · University Of Michigan At Ann Arbor · R01 · FY2011 · HL

Proteins of Coagulation Pathways

$569,345
John H Griffin · Scripps Research Institute, The · R01 · FY2014 · HL

Microglial heparan sulfate in the modulation of APOE function and neurodegeneration

$569,341
Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AG

Diabetes and Aging in a Multi-Ethnic Population

$569,331
Andrew John Karter · Kaiser Foundation Research Institute · R01 · FY2011 · DK

ALIMENTARY TRACT LIPIDS IN HEALTH AND DISEASE

$569,275
Brigham And Women'S Hospital · R01 · FY2003 · DK

Targeting the orphan nuclear receptor LRH-1 with small molecules

$569,274
Eric A Ortlund · Emory University · R01 · FY2023 · DK

FXPOI: Mechanisms and Modifiers

$569,247
Emily Graves Allen · Baylor College Of Medicine · P50 · FY2023 · HD

Baltimore Partnership Program to Reduce Cardiovascular Disparities

$569,222
Reed A Winston · Bon Secours Hospital Baltimore, Inc. · U01 · FY2008 · HL

Novel IP6K1 inhibitors for treatment of NAFLD/NASH

$569,142
Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DK

Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II

$569,078
Raymond L Ownby · Nova Southeastern University · R56 · FY2015 · HL

Mechanistic function of HCV NS5A targeted by the potent inhibitors

$569,025
Minkyung Yi · University Of Texas Med Br Galveston · R01 · FY2020 · AI

The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome

$568,991
Anuja Dokras-Jagasia · University Of Pennsylvania · R01 · FY2019 · HD

SELF DETERMINATION, SMOKING, DIET, AND HEALTH

$568,939
University Of Rochester · R01 · FY2001 · MH

Significance and mechanisms of hepatic ChREBPα induction via post-translational modifications in diet-induced NASH

$568,905
Lei Yin · University Of Michigan At Ann Arbor · R01 · FY2025 · DK